William Blake

Tychon Biosciences LLC is a company based in Minneapolis, MN that is advancing precision cancer immunotherapy through a novel approach that transforms a patient’s immune cells into a “par-t” cell trained to find and eliminate cancer cells. Tychon's par-t technology can be used as a primary therapy or in combination with other therapies, opening up enormous untapped potential to treat early and late-stage cancers. The company's therapy delivers on the promise of T-cell based immunotherapy by addressing the shortcomings with a novel approach. The company has introduced Tyc201a, a protein-based drug that activates T-cells to find and eliminate cancer. The company was founded by Troy D. Kopischke and the CEO is Danny J. Cunagin.

ImBio LLC engages in the development of medical imaging devices. It offers lung density analysis and lung texture analysis. The company was founded by Brian Ross and Alnawaz Rehemtulla and is headquartered in Minneapolis, MN.

Logic PD, Inc. provides product design, engineering and electronic manufacturing services. It also engages in the design, development and delivery of embedded technology. It serves the aerospace and defense, commercial and industrial, and medical and life science market. The company was founded in 1960 and is headquartered in Minneapolis, MN.

Mekanistic Therapeutics LLC designs, discovers and develops cancer therapeutics through developing anti-cancer agents. The company was founded by Christopher Whitehead and Judith Sebolt-Leopold and is headquartered in Ann Arbor, MI.

Exosite LLC develops internet of things platform tool for accessing and analyzing data. It provides home automation, condition monitoring and industry solutions. The company was founded in 2009 and is headquartered in Minneapolis, MN.

Gene Matters LLC engages in the provision of genetic counseling services. It serves genetic counselors, management team, and advisors. The company was founded by Jill Davies in 2016 and is headquartered in Minneapolis, MN.

Invenshure LLC (Invenshure) is a venture capital firm founded in 2011 by Troy D Kopischke and Danny J Cunagin. The firm is headquartered in Minneapolis, Minnesota.

Vizgen, Inc. engages in business of biotechnology. The company was founded in 2019 and is headquartered in Cambridge, MA.

Enko Chem, Inc. operates as a biotechnology company. The company was founded by Jacqueline Heard and is headquartered in Boston, MA.

Animol Discovery develops small molecule drugs for animals. The company was founded by Phil Austin in 2019 and is headquartered in Boston, MA.

eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium.

Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018.

OneOme LLC develops platform for pharmacogenomics that analyzes multiple genes for accurate and comprehensive prescription recommendations. It specializes in pharmacogenetics, pharmacogenomics, genetics, biotech and life sciences and clinical decision support. The company was founded by John L. Black III and Troy D. Kopischke in 2014 and is headquartered in Minneapolis, MN.

Eight Enterprises LLC (8VC) is a private equity/venture capital firm founded in 2015 by Joseph T. Lonsdale. The firm is headquartered in San Francisco, California.

BlueVoyant LLC engages in the provision of cybersecurity services. It offers third party cyber risk service, managed security services, threat intelligence, and professional services. The company was founded by Thomas Henry Glocer and James A. Rosenthal in July 2017 and is headquartered in New York, NY.

Mantra Bio, Inc. develops deep data platform for exosome discovery. It focuses on harnessing naturally occurring human exosomes to develop safe, ultra-targeted therapies to combat intractable diseases. The company is headquartered in San Francisco, CA.

Appia Bio, Inc. is an early stage biotechnology company based in an undisclosed location. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. The American company utilizes the biology of lymphocyte development with chimeric antigen receptor (CAR) and T cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-NKT) or gamma delta T cells from hematopoietic stem cells (HSCs) with its ACUA (Appia Cells Utilized for Allogeneic) technology platform. The ACUA platform was developed from groundbreaking research in the laboratory of Lili Yang, Ph.D., at the University of California, and collaboration with Appia Bio's other scientific founders, David Baltimore, Ph.D. at Caltech and Pin Wang, Ph.D. at the University of Southern California. The company was founded in 2020 by Jeffrey S. Wiezorek, David Baltimore, Jeenjoo Kang, Lili Yang, Edmund Kim, and Pin Wang. Jeenjoo Kang has been the CEO since 2020.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

Bundesverband der Deutschen Industrie e.V. provides information on the German industry, economy, and economic policies. The private company is based in Berlin, Germany. The German company organizes events that bring together business, politics, science, and civil society for discussions, whether virtually, in-person, or hybrid. The company was founded by Gerhard Schempp.

The Business Council operates as an organization of business leaders. The company is headquartered in Washington, DC.

The Business Roundtable advocates public policies that ensure economic growth. It considers public policy issues which contains groups like the construction users anti-inflation roundtable, a group devoted to containing construction costs; and the labor law study committee, made up of labor relations executives of major companies. The Business Roundtable was founded in 1972 and is headquartered in Washington, DC.

Q-SI Operations, Inc. develops protein sequencing technologies to decode molecules life. The company was founded by Jonathan Rothberg and is headquartered in Guilford, CT.

Novalis Lifesciences LLC (Novalis Lifesciences ) is a venture capital firm founded in 2013 by Marijn E. Dekkers. The firm is headquartered in Hampton, New Hampshire.

Cerevel Therapeutics LLC operates as a biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system. The company was founded in 2018 and is headquartered in Boston, MA.

Ginkgo Bioworks, Inc. engages in the development of microbe for different applications. Its organisms can be used for fuels, flavorings, fragrances, cosmetics, and pharmaceutical products. The company was founded by Thomas F. Knight Jr., Austin Che, Reshma Shetty, Bartholomew Canton and Jason Kelly in 2008 and is headquartered in Boston, MA.

Foundation for the National Institutes of Health, Inc. provides healthcare services. It offers services to public health through scientific discovery, translational research and dissemination of research results through public-private partnerships. The organization was founded in 1996 and is headquartered in Bethesda, MD

Unilever International Holdings NV operates as an investment holding company. The company is headquartered in Rotterdam, the Netherlands.

BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA.